Logo image of CNRI.CA

CANADIAN NORTH RESOURCES INC (CNRI.CA) Stock Fundamental Analysis

TSX-V:CNRI - TSX Venture Exchange - CA1364271017 - Common Stock - Currency: CAD

1  -0.03 (-2.91%)

Fundamental Rating

2

Taking everything into account, CNRI scores 2 out of 10 in our fundamental rating. CNRI was compared to 822 industry peers in the Metals & Mining industry. While CNRI seems to be doing ok healthwise, there are quite some concerns on its profitability. CNRI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNRI had negative earnings in the past year.
In the past year CNRI has reported a negative cash flow from operations.
CNRI had negative earnings in each of the past 5 years.
In the past 5 years CNRI always reported negative operating cash flow.
CNRI.CA Yearly Net Income VS EBIT VS OCF VS FCFCNRI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

CNRI has a Return On Assets of -8.04%. This is in the better half of the industry: CNRI outperforms 65.45% of its industry peers.
The Return On Equity of CNRI (-8.80%) is better than 68.00% of its industry peers.
Industry RankSector Rank
ROA -8.04%
ROE -8.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNRI.CA Yearly ROA, ROE, ROICCNRI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CNRI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNRI.CA Yearly Profit, Operating, Gross MarginsCNRI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023

More info and screens

5

2. Health

2.1 Basic Checks

CNRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CNRI.CA Yearly Shares OutstandingCNRI.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M 80M 100M
CNRI.CA Yearly Total Debt VS Total AssetsCNRI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

An Altman-Z score of 15.81 indicates that CNRI is not in any danger for bankruptcy at the moment.
CNRI's Altman-Z score of 15.81 is amongst the best of the industry. CNRI outperforms 80.85% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that CNRI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, CNRI is in line with its industry, outperforming 50.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 15.81
ROIC/WACCN/A
WACCN/A
CNRI.CA Yearly LT Debt VS Equity VS FCFCNRI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

2.3 Liquidity

CNRI has a Current Ratio of 2.75. This indicates that CNRI is financially healthy and has no problem in meeting its short term obligations.
CNRI has a Current ratio of 2.75. This is in the better half of the industry: CNRI outperforms 63.39% of its industry peers.
A Quick Ratio of 2.75 indicates that CNRI has no problem at all paying its short term obligations.
CNRI has a better Quick ratio (2.75) than 65.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75
CNRI.CA Yearly Current Assets VS Current LiabilitesCNRI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

CNRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -117.83%.
EPS 1Y (TTM)-117.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNRI.CA Yearly Revenue VS EstimatesCNRI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023
CNRI.CA Yearly EPS VS EstimatesCNRI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CNRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNRI.CA Price Earnings VS Forward Price EarningsCNRI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNRI.CA Per share dataCNRI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CNRI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANADIAN NORTH RESOURCES INC

TSX-V:CNRI (3/7/2025, 7:00:00 PM)

1

-0.03 (-2.91%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.36%
Ins Owner ChangeN/A
Market Cap114.53M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.6
P/tB 2.6
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.04%
ROE -8.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2153.28%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z 15.81
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)19249.2%
Cap/Depr(5y)11923.7%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.22%
OCF growth 3YN/A
OCF growth 5YN/A